WuXi AppTec Co., Ltd. (OTCMKTS:WUXAY – Get Free Report) shares saw an uptick in trading volume on Monday after Zacks Research upgraded the stock from a hold rating to a strong-buy rating. 4,049 shares traded hands during trading, an increase of 85% from the previous session’s volume of 2,186 shares.The stock last traded at $24.74 and had previously closed at $24.98.
WuXi AppTec Stock Performance
The business’s 50 day moving average price is $19.14 and its 200 day moving average price is $16.77.
About WuXi AppTec
WuXi AppTec is a global contract research, development and manufacturing organization serving the pharmaceutical, biotechnology and medical device industries. Headquartered in Shanghai and founded in 2000, the company provides end-to-end solutions that span drug discovery, development and manufacturing. Its offerings enable customers to accelerate the research and development process for small molecules, biologics, cell and gene therapies, as well as medical devices.
Key services include chemistry and biology discovery support, preclinical safety assessment, analytical and formulation development, clinical manufacturing, large-scale biomanufacturing, and quality testing.
See Also
- Five stocks we like better than WuXi AppTec
- Atlassian Just Pulled Off the Software Comeback Wall Street Wanted
- AST SpaceMobile Earnings Just Reminded Investors How Risky Space Can Be
- NVIDIA’s Rally Sets Up a Bigger Test Ahead of Earnings
- Apple’s Next iPhone Could Test How Much Pricing Power Is Left
Receive News & Ratings for WuXi AppTec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for WuXi AppTec and related companies with MarketBeat.com's FREE daily email newsletter.
